This study involved four major activities for estimating the current size of the Patient access solutions market. Exhaustive secondary research was conducted to collect information on the market and its peer and parent markets. The next step focused on validating these findings, assumptions, and sizing with industry experts across the value chain through primary research. Revenue Share Analysis, Parent Market, and top-down approaches were employed to estimate the complete market size.
Increasing patient volume and subsequent growth in the demand for health insurance, the growing importance of denials management, declining reimbursement rates, increase in the volume of unstructured data in the healthcare industry, and the rising need to curtail escalating healthcare costs are the major factors driving the growth of this market. However, high deployment costs are expected to restrain the growth of this market to a certain extent.
The global patient access solutions market is projected to reach USD 2.4 billion by 2025 from USD 1.6 billion in 2020, at a CAGR of 8.5%.
COVID-19 Impact on the Patient access solutions Market :
Coronavirus has spread across 215 countries and territories and affected more than 4.4 million people, with close to 300 thousand deaths. The pandemic has had considerable social and economic ramifications across a variety of industries and sectors. As of 28 October 2020, there have been 44,235,263 reported cases of COVID-19 (Source: Worldometer) from Africa, Asia Pacific, the Americas, Europe, and Oceania. The virus has resulted in 1,171,288 deaths.
The true number of infected people would be much higher than the official total, as a large number of cases are asymptomatic and do not undergo testing.It could be assumed that there is a drastic change in the size of the Patient access solutions market. Due to the COVID-19 outbreak, medical practices of all sizes are under immense pressure, and healthcare facilities across the globe have been overwhelmed by the large number of patients visiting them on a daily basis.
Download PDF Brochure: h
Services segment to have the largest share in 2019
Based on product and service, the patient access solutions market is segmented into services and software. The services segment accounted for the largest share of the global patient access solutions market in 2019. The introduction of complex software and the need for system integration are expected to boost the services market in the coming years.
The web & cloud-based solution segment accounted for the largest market share in 2019
Based on delivery mode, the patient access solutions market is segmented into web and cloud-based solutions and on-premise solutions. In 2019, the web and cloud-based solutions segment accounted for the largest share of the global patient access solutions market. The flexibility of working from remote areas, affordability, and automated updating features are some of the key advantages associated with web and cloud-based solutions.
APAC market to witness the highest growth during the forecast period
The Asia Pacific market is comparatively new to patient access solutions; however, this region is expected to register the highest growth in the coming years. Countries such as Japan, Australia, New Zealand, South Korea, and Singapore are expected to provide significant growth opportunities for vendors of patient access solutions.
Request Sample Report: www.marketsandmarkets.com/requestsampleNew.asp?id=280473
Key Market Players :
The Patient access solutions market is highly competitive and fragmented. The prominent players operating in this market include Cognizant (US), McKesson Corporation (US), Cerner Corporation (US), Experian (Ireland), 3M (US), Conifer (US), Waystar (US), Epic Systems (US), SSI Group (US), Optum (US), Cirius Group (US), Craneware (US), Allscripts (US), Genentech (Ireland), AccuReg Software (US), Kyruus (US), AccessOne (US), Vee Technologies (India), Exela Technologies (US), QWay Health (US), TransUnion (US), PLEXIS Healthcare Systems (US), HealthAsyst (India), and Virtusa (US).